Skip to main content
. 2019 Mar 27;10:236. doi: 10.3389/fphar.2019.00236

Figure 2.

Figure 2

The relationship between TRIB3 (251, A > G) genetic polymorphism and the hypotensive effects of the antihypertensives monotherapy in EH patients. Panels (A–C) respectively depicts that BP-changes from baseline in EH patients carrying the TRIB3 (251, A > G) AA and AG/GG genotypes after treatment with the drugs of CCBs, ARBs and ACEIs for 6 weeks. P-value were calculated by the linear mixed model and adjusted for baseline age, BMI, gender, SBP, DBP, total cholesterol, heart rate, triglyceride, HDL, LDL, FBG and other biochemical factors appropriately. Error bar indicated 95% confidence interval.